Morgan Stanley’s Spruce Biosciences, Inc. Common Stock SPRB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-7,396
| Closed | -$2.15K | – | 8347 |
|
|
2025
Q1 | $2.15K | Buy |
7,396
+5,263
| +247% | +$1.53K | ﹤0.01% | 7163 |
|
|
2024
Q4 | $896 | Hold |
2,133
| – | – | ﹤0.01% | 7289 |
|
|
2024
Q3 | $1.01K | Hold |
2,133
| – | – | ﹤0.01% | 7217 |
|
|
2024
Q2 | $1.1K | Sell |
2,133
-19,390
| -90% | -$10K | ﹤0.01% | 7141 |
|
|
2024
Q1 | $16.9K | Buy |
21,523
+17,257
| +405% | +$13.6K | ﹤0.01% | 6539 |
|
|
2023
Q4 | $12.5K | Buy |
4,266
+2,135
| +100% | +$6.26K | ﹤0.01% | 6784 |
|
|
2023
Q3 | $4.82K | Hold |
2,131
| – | – | ﹤0.01% | 6923 |
|
|
2023
Q2 | $4.58K | Sell |
2,131
-1,019
| -32% | -$2.19K | ﹤0.01% | 7006 |
|
|
2023
Q1 | $6.96K | Sell |
3,150
-189
| -6% | -$418 | ﹤0.01% | 6985 |
|
|
2022
Q4 | $3.66K | Sell |
3,339
-19,835
| -86% | -$21.8K | ﹤0.01% | 7233 |
|
|
2022
Q3 | $31K | Sell |
23,174
-37,486
| -62% | -$50.1K | ﹤0.01% | 6614 |
|
|
2022
Q2 | $106K | Buy |
60,660
+49,239
| +431% | +$86K | ﹤0.01% | 6244 |
|
|
2022
Q1 | $22K | Sell |
11,421
-970
| -8% | -$1.87K | ﹤0.01% | 7112 |
|
|
2021
Q4 | $55K | Sell |
12,391
-63,520
| -84% | -$282K | ﹤0.01% | 6770 |
|
|
2021
Q3 | $456K | Sell |
75,911
-46,679
| -38% | -$280K | ﹤0.01% | 5556 |
|
|
2021
Q2 | $1.38M | Buy |
122,590
+88,298
| +257% | +$990K | ﹤0.01% | 4897 |
|
|
2021
Q1 | $569K | Buy |
34,292
+28,963
| +543% | +$481K | ﹤0.01% | 5080 |
|
|
2020
Q4 | $129K | Buy |
+5,329
| New | +$129K | ﹤0.01% | 5806 |
|